Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir Add-on vs Entecavir Switch in Lamivudine-Resistant Chronic Hepatitis B
NCT00531167Phase 4Completed
- Sponsor
- Korea University
- Start
- Apr 2007
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of adefovir dipivoxil in Chronic Hepatitis B (CHB) (2 arms), sponsored by Korea University. Primary endpoint: PCR negativity (<60 IU/ml) of HBV DNA at 2 years. Started Apr 2007; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00531167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531167.